Sign in Subscribe

Trump Admin Eyes Major GLP-1 Weight Loss Drug Coverage

The Trump administration is considering a five-year pilot program for Medicare & Medicaid to cover costly GLP-1 weight-loss drugs like Wegovy & Zepbound for millions, a significant policy shift.

Trump Admin Eyes Major GLP-1 Weight Loss Drug Coverage
Photo by Haberdoedas on Unsplash

This post is for paying subscribers only

Already have an account? Sign in.